AstraZeneca PLC Faces Investigation into China President Leon Wang

AstraZeneca PLC, a multinational pharmaceutical company, is facing investigation into its China President, Leon Wang. The investigation comes at a time when AstraZeneca has been making headlines with its successful COVID-19 vaccine. The Chinese authorities have not disclosed the reasons behind the investigation, leading to speculation and uncertainty in the market. Investors should closely monitor the developments and seek professional guidance, such as Stocks Prognosis, to make informed decisions about the future movement of AstraZeneca's stock.